The phase 3 POTOMAC trial tested durvalumab added to BCG in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).

Adding durvalumab to induction and maintenance with Bacillus Calmette–Guérin (BCG) can improve disease-free survival in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer, data ...

Hyderabad collector Harichandana Dasari told Deccan Chronicle that Telangana maintains high immunisation coverage through ...

Upper Bann MP Carla Lockhart has welcomed confirmation that TB vaccination trials are reaching the final stages, but says ...

The vaccines imported and used for Expanded Programme on Immunization (EPI), Bivalent Oral Polio Vaccine (bOPV), BCG and Tetanus-Diphtheria are 100 percent procured from the WHO-PQ sources through ...